Circulating Biomarker for Liquid Biopsy and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Circulating Biomarker for Liquid Biopsy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Circulating Biomarker for Liquid Biopsy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Circulating Biomarker for Liquid Biopsy Overall Market Size
2.1 Global Circulating Biomarker for Liquid Biopsy Market Size: 2022 VS 2030
2.2 Global Circulating Biomarker for Liquid Biopsy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Circulating Biomarker for Liquid Biopsy Players in Global Market
3.2 Top Global Circulating Biomarker for Liquid Biopsy Companies Ranked by Revenue
3.3 Global Circulating Biomarker for Liquid Biopsy Revenue by Companies
3.4 Top 3 and Top 5 Circulating Biomarker for Liquid Biopsy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Circulating Biomarker for Liquid Biopsy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Circulating Biomarker for Liquid Biopsy Players in Global Market
3.6.1 List of Global Tier 1 Circulating Biomarker for Liquid Biopsy Companies
3.6.2 List of Global Tier 2 and Tier 3 Circulating Biomarker for Liquid Biopsy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Circulating Biomarker for Liquid Biopsy Market Size Markets, 2022 & 2030
4.1.2 Circulating Tumor Cells (CTCs)
4.1.3 Circulating Tumor DNA (ctDNA)
4.1.4 Cell-Free DNA (cfDNA)
4.1.5 Extracellular Vesicles (EVs)
4.1.6 Others
4.2 By Type - Global Circulating Biomarker for Liquid Biopsy Revenue & Forecasts
4.2.1 By Type - Global Circulating Biomarker for Liquid Biopsy Revenue, 2018-2023
4.2.2 By Type - Global Circulating Biomarker for Liquid Biopsy Revenue, 2024-2030
4.2.3 By Type - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Circulating Biomarker for Liquid Biopsy Market Size, 2022 & 2030
5.1.2 Early Cancer Screening
5.1.3 Therapy Selection
5.1.4 Treatment Monitoring
5.1.5 Recurrence Monitoring Orthopedics
5.2 By Application - Global Circulating Biomarker for Liquid Biopsy Revenue & Forecasts
5.2.1 By Application - Global Circulating Biomarker for Liquid Biopsy Revenue, 2018-2023
5.2.2 By Application - Global Circulating Biomarker for Liquid Biopsy Revenue, 2024-2030
5.2.3 By Application - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Circulating Biomarker for Liquid Biopsy Market Size, 2022 & 2030
6.2 By Region - Global Circulating Biomarker for Liquid Biopsy Revenue & Forecasts
6.2.1 By Region - Global Circulating Biomarker for Liquid Biopsy Revenue, 2018-2023
6.2.2 By Region - Global Circulating Biomarker for Liquid Biopsy Revenue, 2024-2030
6.2.3 By Region - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Circulating Biomarker for Liquid Biopsy Revenue, 2018-2030
6.3.2 US Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.3.3 Canada Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.3.4 Mexico Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Circulating Biomarker for Liquid Biopsy Revenue, 2018-2030
6.4.2 Germany Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.4.3 France Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.4.4 U.K. Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.4.5 Italy Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.4.6 Russia Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.4.7 Nordic Countries Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.4.8 Benelux Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Circulating Biomarker for Liquid Biopsy Revenue, 2018-2030
6.5.2 China Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.5.3 Japan Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.5.4 South Korea Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.5.5 Southeast Asia Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.5.6 India Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Circulating Biomarker for Liquid Biopsy Revenue, 2018-2030
6.6.2 Brazil Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.6.3 Argentina Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Circulating Biomarker for Liquid Biopsy Revenue, 2018-2030
6.7.2 Turkey Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.7.3 Israel Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.7.4 Saudi Arabia Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
6.7.5 UAE Circulating Biomarker for Liquid Biopsy Market Size, 2018-2030
7 Circulating Biomarker for Liquid Biopsy Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.1.4 Abbott Laboratories Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Becton, Dickinson and Company
7.2.1 Becton, Dickinson and Company Company Summary
7.2.2 Becton, Dickinson and Company Business Overview
7.2.3 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.2.4 Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2018-2023)
7.2.5 Becton, Dickinson and Company Key News & Latest Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Company Summary
7.3.2 GE Healthcare Business Overview
7.3.3 GE Healthcare Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.3.4 GE Healthcare Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2018-2023)
7.3.5 GE Healthcare Key News & Latest Developments
7.4 Epigenomics AG
7.4.1 Epigenomics AG Company Summary
7.4.2 Epigenomics AG Business Overview
7.4.3 Epigenomics AG Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.4.4 Epigenomics AG Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2018-2023)
7.4.5 Epigenomics AG Key News & Latest Developments
7.5 Agilent Technologies
7.5.1 Agilent Technologies Company Summary
7.5.2 Agilent Technologies Business Overview
7.5.3 Agilent Technologies Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.5.4 Agilent Technologies Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2018-2023)
7.5.5 Agilent Technologies Key News & Latest Developments
7.6 Biocept
7.6.1 Biocept Company Summary
7.6.2 Biocept Business Overview
7.6.3 Biocept Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.6.4 Biocept Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2018-2023)
7.6.5 Biocept Key News & Latest Developments
7.7 Affymetrix
7.7.1 Affymetrix Company Summary
7.7.2 Affymetrix Business Overview
7.7.3 Affymetrix Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.7.4 Affymetrix Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2018-2023)
7.7.5 Affymetrix Key News & Latest Developments
7.8 Fluxion Biosciences
7.8.1 Fluxion Biosciences Company Summary
7.8.2 Fluxion Biosciences Business Overview
7.8.3 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Major Product Offerings
7.8.4 Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Revenue in Global Market (2018-2023)
7.8.5 Fluxion Biosciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Circulating Biomarker for Liquid Biopsy Market Opportunities & Trends in Global Market
Table 2. Circulating Biomarker for Liquid Biopsy Market Drivers in Global Market
Table 3. Circulating Biomarker for Liquid Biopsy Market Restraints in Global Market
Table 4. Key Players of Circulating Biomarker for Liquid Biopsy in Global Market
Table 5. Top Circulating Biomarker for Liquid Biopsy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Circulating Biomarker for Liquid Biopsy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Circulating Biomarker for Liquid Biopsy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Circulating Biomarker for Liquid Biopsy Product Type
Table 9. List of Global Tier 1 Circulating Biomarker for Liquid Biopsy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Circulating Biomarker for Liquid Biopsy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Circulating Biomarker for Liquid Biopsy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Circulating Biomarker for Liquid Biopsy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Circulating Biomarker for Liquid Biopsy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Circulating Biomarker for Liquid Biopsy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2024-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Product Offerings
Table 32. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Becton, Dickinson and Company Company Summary
Table 35. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Product Offerings
Table 36. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn) & (2018-2023)
Table 37. Becton, Dickinson and Company Key News & Latest Developments
Table 38. GE Healthcare Company Summary
Table 39. GE Healthcare Circulating Biomarker for Liquid Biopsy Product Offerings
Table 40. GE Healthcare Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn) & (2018-2023)
Table 41. GE Healthcare Key News & Latest Developments
Table 42. Epigenomics AG Company Summary
Table 43. Epigenomics AG Circulating Biomarker for Liquid Biopsy Product Offerings
Table 44. Epigenomics AG Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn) & (2018-2023)
Table 45. Epigenomics AG Key News & Latest Developments
Table 46. Agilent Technologies Company Summary
Table 47. Agilent Technologies Circulating Biomarker for Liquid Biopsy Product Offerings
Table 48. Agilent Technologies Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn) & (2018-2023)
Table 49. Agilent Technologies Key News & Latest Developments
Table 50. Biocept Company Summary
Table 51. Biocept Circulating Biomarker for Liquid Biopsy Product Offerings
Table 52. Biocept Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn) & (2018-2023)
Table 53. Biocept Key News & Latest Developments
Table 54. Affymetrix Company Summary
Table 55. Affymetrix Circulating Biomarker for Liquid Biopsy Product Offerings
Table 56. Affymetrix Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn) & (2018-2023)
Table 57. Affymetrix Key News & Latest Developments
Table 58. Fluxion Biosciences Company Summary
Table 59. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Product Offerings
Table 60. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Revenue (US$, Mn) & (2018-2023)
Table 61. Fluxion Biosciences Key News & Latest Developments
List of Figures
Figure 1. Circulating Biomarker for Liquid Biopsy Segment by Type in 2022
Figure 2. Circulating Biomarker for Liquid Biopsy Segment by Application in 2022
Figure 3. Global Circulating Biomarker for Liquid Biopsy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Circulating Biomarker for Liquid Biopsy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Circulating Biomarker for Liquid Biopsy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Circulating Biomarker for Liquid Biopsy Revenue in 2022
Figure 8. By Type - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
Figure 16. US Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
Figure 20. Germany Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 21. France Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
Figure 28. China Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 32. India Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
Figure 34. Brazil Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Circulating Biomarker for Liquid Biopsy Revenue Market Share, 2018-2030
Figure 37. Turkey Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Circulating Biomarker for Liquid Biopsy Revenue, (US$, Mn), 2018-2030
Figure 41. Abbott Laboratories Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Becton, Dickinson and Company Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GE Healthcare Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Epigenomics AG Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Agilent Technologies Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Biocept Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Affymetrix Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Fluxion Biosciences Circulating Biomarker for Liquid Biopsy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
